DICERNA Trademark

Trademark Overview

On Friday, November 15, 2019, a trademark application was filed for DICERNA with the United States Patent and Trademark Office. The USPTO has given the DICERNA trademark a serial number of 88694422. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The DICERNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
dicerna

General Information

Serial Number88694422
Word MarkDICERNA
Filing DateFriday, November 15, 2019
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7115639
Registration DateTuesday, July 18, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Description of MarkThe mark consists of "DICERNA" in stylized white letters on a blue background.
Indication of Colors claimedThe color(s) white and blue is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code042
First Use Anywhere DateFriday, May 26, 2023
First Use In Commerce DateFriday, May 26, 2023

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Wednesday, January 22, 2020ASSIGNED TO LIE
Tuesday, November 19, 2019NEW APPLICATION ENTERED
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 10, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 22, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Tuesday, February 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 27, 2020SOU TEAS EXTENSION RECEIVED
Friday, November 27, 2020SOU EXTENSION 1 FILED
Friday, November 27, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, May 25, 2021SOU EXTENSION 2 FILED
Tuesday, May 25, 2021SOU EXTENSION 2 GRANTED
Thursday, May 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 17, 2021SOU EXTENSION 3 FILED
Wednesday, November 17, 2021SOU EXTENSION 3 GRANTED
Friday, November 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 25, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 25, 2022SOU EXTENSION 4 FILED
Wednesday, May 25, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 22, 2022SOU EXTENSION 5 FILED
Friday, December 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 2, 2022SOU EXTENSION 5 GRANTED
Saturday, December 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 26, 2023TEAS STATEMENT OF USE RECEIVED
Friday, May 26, 2023USE AMENDMENT FILED
Wednesday, May 31, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 14, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 15, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

dicerna research development diseases scientific disorders liver medical treatment oligonucleotide compounds